THOMAS W FEELEY to Health Care Costs
This is a "connection" page, showing publications THOMAS W FEELEY has written about Health Care Costs.
Connection Strength
2.691
-
Using Time-Driven Activity-Based Costing to Model the Costs of Various Process-Improvement Strategies in Acute Pain Management. J Healthc Manag. 2018 Jul-Aug; 63(4):e76-e85.
Score: 0.428
-
Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program. J Oncol Pract. 2018 02; 14(2):e103-e112.
Score: 0.412
-
Outcome Measurement in Value-Based Payments. JAMA Oncol. 2017 08 01; 3(8):1019-1020.
Score: 0.401
-
How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved? Oncology (Williston Park). 2016 May; 30(5):468-74.
Score: 0.368
-
Value based care and bundled payments: Anesthesia care costs for outpatient oncology surgery using time-driven activity-based costing. Healthc (Amst). 2016 Sep; 4(3):173-80.
Score: 0.352
-
Comparative costs of advanced proton and photon radiation therapies: lessons from time-driven activity-based costing in head and neck cancer. J Comp Eff Res. 2015 Aug; 4(4):297-301.
Score: 0.349
-
Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-Driven Activity-Based Costing. Urology. 2021 11; 157:107-113.
Score: 0.133
-
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy. 2016 May-Jun; 15(3):274-282.
Score: 0.091
-
Outcome and cost implications of cardiopulmonary resuscitation in the medical intensive care unit of a comprehensive cancer center. Support Care Cancer. 2002 Jul; 10(5):425-9.
Score: 0.035
-
Improving efficiency and reducing costs of MRI-Guided prostate brachytherapy using Time-Driven Activity-Based costing. Brachytherapy. 2022 Jan-Feb; 21(1):49-54.
Score: 0.033
-
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study. Brachytherapy. 2018 Mar - Apr; 17(2):265-276.
Score: 0.026
-
Communicating Value in Health Care Using Radar Charts: A Case Study of Prostate Cancer. J Oncol Pract. 2016 09; 12(9):813-20.
Score: 0.024
-
Using Quality Improvement Methods and Time-Driven Activity-Based Costing to Improve Value-Based Cancer Care Delivery at a Cancer Genetics Clinic. J Oncol Pract. 2016 Mar; 12(3):e320-31.
Score: 0.023
-
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. 2012 May 15; 118(10):2571-82.
Score: 0.017